Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer

NCT00411528 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

185

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Hormone Refractory Prostate Cancer

Interventions

DRUG: Patupilone
DRUG: prednisone
DRUG: docetaxel

Sponsor

Novartis Pharmaceuticals